Helping businesses secure and maximise R&D tax credits and grants

London: 0207 118 6045
Market Harborough: 01858 776 045

info@myriadassociates.com

Pharmaceutical

If your company is in the pharmaceutical industry and you've recently introduced a new drug or developed a new piece of technology then there is a strong chance that you could benefit from an R&D Tax Credit claim.

Pharmaceutical

R&D Tax Credits for Pharmaceutical Explained

What type of pharmaceutical projects can qualify for R&D tax credits?

Although similar to other industries, the types of pharmaceutical activities considered R&D are different due to the nature of testing procedures required to meet regulatory requirements. The time taken from the earliest research stages on a particular drug to market is usually in the order of a decade. And only a small percentage of promising compounds identified in early research end up with regulatory approval.

What projects can be included in an R&D Tax Credit claim for the Pharmaceutical industry?

R&D in the pharmaceutical industry typically takes place in four stages:

  • Drug discovery

This phase is concerned with the identification of promising new chemical entities.

  • Pre-clinical trials

Pre-clinical trials are concerned with the non-human testing of compounds. Compounds that are identified as promising at the pre-clinical trial stage move into clinical trials.

  • Clinical trials

Clinical trials go through three phases, they could generally be described as toxicity tests (phase 1), preliminary efficacy tests (phase 2) and comparative efficacy and tolerability tests (phase 3). Work in these first 3 stages will likely be considered R&D. This will likely include work on applying to and responding to the regulator, and work on doing further testing as requested by the regulator. Most of the work involved in making an application to the regulator would involve work that directly contributes to the resolution of technological uncertainty and would therefore qualify as R&D.

  • Post-launch

The post-launch phase occurs when a product has been licensed. Thus this phase involves post-marketing confirmatory studies, special interest studies, longer-term efficacy, tolerability etc. Work in this phase would generally not be considered R&D unless the work involved a scientific or technologically advanced uncertainty.

How to decide what qualifies as R&D in the Pharmaceutical industry?

It seems to be the case that the research activities of discovery, pre-clinical development and Phase 1-3 trials will usually be concerned with the resolution of scientific and technological uncertainty, but that phase 4 (post-launch trials) will not. Our experience has shown that this is generally an appropriate starting point for examination of claims from pharmaceutical companies. If there are unusual circumstances meaning R&D is done in Phase 4 trials, or not done in some elements of phase 1-3 trials, then this can be examined further. What is important with every claim is that the company claiming can demonstrate by reference, what it has actually done and that the expenditure incurred is based on R&D.

How Myriad Associates Can Help

Why choose Myriad Associates as your specialist R&D tax credits advisor?

By profiting from our specialist knowledge and experience, you can be sure of maximising your R&D tax relief claim. As a rule, Myriad Associates submit R&D tax relief claims that are up to three times higher than in-house prepared claims or those filed by generalist accountants.

  • We handle your R&D claim from start to finish, taking up just two to three hours of your time.
  • We can maximise your R&D claim because our expert consultants can identify your qualifying projects and all your eligible expenses.
  • We write technical reports describing your projects to support your claims.
  • We make sure HMRC handles your claim promptly, because of our right-first-time approach and because of our outstanding relationship with R&D tax inspectors.
  • Our 5-Step Claim Process is simplicity in itself, so you always know where we are with your claim.

We identify all your R&D activities

We capture all your R&D expenditure

We write your R&D technical reports

We submit your R&D Tax Relief claim

We work with HMRC to agree your R&D claim

With just two to three hours of your time we'll take care of your claim from start to finish

  • 100% success. We have successfully claimed R&D tax relief for all our clients, for over ten years, and without exception.
  • An unbeatable offer. Confident of delivering a winning service, we offer our services on a success-only basis.

Client Testimonials

At Myriad Associates, we've had the opportunity to provide R&D Tax Credit claim services for some of the UK's most innovative pharmaceutical companies.

Cleaver Scientific Limited

Cleaver Scientific is a UK based electrophoresis equipment supplier who provide premium and technically enhanced high-specification, low-cost electrophoresis equipment for the world market.

It was clear that Myriad Associates were not just very knowledgable about the R&D Tax Relief Scheme, they also made it their business to understand our technology, process and business costs model.

Adie Cleaver, Managing Director, Cleaver Scientific Limited

R&D Calculator

R&D Tax Relief Calculator

This R&D tax credits calculator estimates the amount of corporation tax savings you may be entitled to by making a claim for R&D tax relief.

free r&d tax calculator

What our clients say

Get in touch

Please contact us to discuss how working with Myriad Associates can maximise and secure R&D funding opportunities for your business.

contact us